Overview

Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.

Status:
Completed
Trial end date:
2020-02-11
Target enrollment:
0
Participant gender:
All
Summary
There is currently no real consensus on the optimal management of acute sprains of the proximal interphalangeal joint of the long fingers. The aim of this study is to assess the beneficial effect of an injection of corticosteroids for the treatment of this type of sprain (one single sub-cutaneous injection, in the acute phase). This treatment, if effective, might become the treatment of choice for these types of injuries, instead of a prolonged immobilization or a careful early mobilization.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Brugmann University Hospital
Treatments:
Betamethasone
Betamethasone dipropionate, betamethasone sodium phosphate drug combination
Criteria
Inclusion Criteria:

- Adults over 18 years old

- Type I and II and III of the Eaton classification (except if fracture/luxation with
more than 50% of the articular surface injured)

- Trauma of one articulation only

- Consultation within 2 weeks of trauma

Exclusion Criteria:

- Patients under 18 years old and over 80 years old

- Pregnant/nursing women

- Eaton classification Type II with a fracture affecting more than 50% of the articular
surface, or persistant instability after reduction.

- Open wounds, nerve lesion with sensitive issue and any wound needing a surgical
intervention

- Underlying pathologies: rhumatological, neurological, congenital (giving
hyperextensive articulations as a result)

- Corticoids allergy

- Infection within the treated zone

- Trauma antecedents at the level of the tendons.